Wordt geladen...
Multiple Source Biosimilar Insulin, What’s a Provider to Do?
In the United States the FDA designates generic products that are bioequivalent as AB substitutable (FDA rating signifying the approved application contains adequate scientific evidence establishing through in vivo and/or in vitro studies the bioequivalence of the product to a selected reference pro...
Bewaard in:
| Gepubliceerd in: | J Diabetes Sci Technol |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4454116/ https://ncbi.nlm.nih.gov/pubmed/24876532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813511748 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|